Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?

This study is currently recruiting participants.

Verified by University of Florida, August 2009

First Received: August 13, 2008 Last Updated: August 11, 2009 History of Changes

Sponsor:	University of Florida
Information provided by:	University of Florida
ClinicalTrials.gov Identifier:	NCT00735111

Purpose

The purpose of this study is to determine if patients are able to self-rate their physical abilities and how these ratings compare to the ratings of their health-care provider.

Condition	Intervention
Cancer	Other: Karnofsky Performance Status Score

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Single Group Assignment
Official Title:	Do Self-Rated Karnofsky Performance Status (KPS) Scores Correlate With Health-Care-Provider-Rated Scores?

Resource links provided by NLM:

MedlinePlus related topics: Cancer

U.S. FDA Resources

Further study details as provided by University of Florida:

Primary Outcome Measures:

To determine the correlation between self-rated and health-care-provider-rated Karnofsky Performance Status scores. [ Time Frame: 5 Years ] [ Designated as safety issue: No ]

Estimated Enrollment:	200
Study Start Date:	February 2008
Estimated Study Completion Date:	January 2014
Estimated Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)

Intervention Details:

Karnofsky Performance Status scores will be independently completed by both the patient and their health-care provider at each routine clinic visit.

Detailed Description:

The Karnofsky Performance Scale (KPS) is a highly validated and essential measuring tool across the cancer population. The scale relates to purely physical ability and covers 11 stages, ranging from normal health to death, with each stage scored as a percentage. The score is determined by the health-care provider and is based on observation and narrative patient descriptions. The purpose of this study is to compare the scores rated by the health-care provider to the scores that patients assign to themselves.

Eligibility

Ages Eligible for Study:	18 Years to 90 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients with a diagnosis of brain or spinal tumor.
Receiving medical care under the supervision of the Principal Investigator.
Written informed consent.

Exclusion Criteria:

None.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00735111

Contacts

Contact: Erin M Dunbar, MD

352-273-9000

edunbar@neurosurgery.ufl.edu

Locations

United States, Florida
University of Florida	Recruiting
Gainesville, Florida, United States, 32610
Contact: Christine Keeling, BSN, OCN 352-273-7981 christine.keeling@neurosurgery.ufl.edu
Principal Investigator: Erin M Dunbar, MD

Sponsors and Collaborators

University of Florida

Investigators

Principal Investigator:

Erin M Dunbar, MD

University of Florida

More Information

No publications provided

Responsible Party:	University of Florida ( Erin M. Dunbar, MD )
Study ID Numbers:	QOL-001
Study First Received:	August 13, 2008
Last Updated:	August 11, 2009
ClinicalTrials.gov Identifier:	NCT00735111 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Florida:

QOL
Quality of Life
KPS
Karnofsky Performance Status
Cancer

ClinicalTrials.gov processed this record on November 30, 2009